{
    "id": "71a854a1-d9af-4f37-a43c-ba3cafafc2c5",
    "indications": "lomaira™ tablets indicated short-term ( weeks ) adjunct regimen weight reduction based exercise , behavioral modification caloric restriction management exogenous obesity patients initial body mass index greater equal 30 kg/m 2 , greater equal 27 kg/m 2in presence risk factors ( e.g . , controlled hypertension , diabetes , hyperlipidemia ) . chart body mass index ( bmi ) based various heights weights . bmi calculated taking patient ’ weight , kilograms ( kg ) , divided patient ’ height , meters ( ) , squared . metric conversions follows : pounds ÷ 2.2 = kg ; inches x 0.0254 = meters . body mass index ( bmi ) , kg/m 2 limited usefulness agents class , including phentermine ( pharmacology ) , measured possible risk factors inherent described .",
    "contraindications": "individualized obtain adequate response lowest effective dose . usual adult dose one tablet three times day ½ hour meals . tablet scored facilitate administering one half usual patients requiring full dose . phentermine hydrochloride recommended pediatric patients less equal 16 years age . late evening medication avoided possibility resulting insomnia .",
    "warningsAndPrecautions": "product : 50090-7560 ndc : 50090-7560-0 90 tablet bottle",
    "adverseReactions": "• history cardiovascular disease ( e.g . , coronary artery disease , stroke , arrhythmias , congestive heart failure , uncontrolled hypertension ) • within 14 days following monoamine oxidase inhibitors • hyperthyroidism • glaucoma • agitated states • history abuse • pregnancy ( ) • nursing ( ) • known hypersensitivity , idiosyncrasy sympathomimetic amines",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "BLUE 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "PHENTERMINE HYDROCHLORIDE",
            "code": "0K2I505OTV"
        }
    ],
    "organization": "A-S Medication Solutions",
    "name": "LOMAIRA",
    "effectiveTime": "20250528",
    "indications_original": "LOMAIRA™ tablets are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity in patients with an initial body mass index greater than or equal to 30 kg/m\n \n  2, or greater than or equal to 27 kg/m\n \n  2in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia).\n\n \n                  Below is a chart of body mass index (BMI) based on various heights and weights.\n                  BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.\n                  BODY MASS INDEX (BMI), kg/m\n \n  2\n                  \n                  \n                     \n                  \n                  The limited usefulness of agents of this class, including phentermine (see\n \n  \n                        Clinical Pharmacology\n                     ), should be measured against possible risk factors inherent in their use such as those described below.",
    "contraindications_original": "Dosage should be individualized to obtain an adequate response with the lowest effective dose. \n    The usual adult dose is one tablet three times a day ½ hour before meals. This tablet is scored to facilitate administering one half of the usual dosage for patients not requiring the full dose. Phentermine hydrochloride is not recommended for use in pediatric patients less than or equal to 16 years of age.\n \n                  Late evening medication should be avoided because of the possibility of resulting insomnia.",
    "warningsAndPrecautions_original": "Product:    50090-7560\n                  NDC:    50090-7560-0   90 TABLET in a BOTTLE",
    "adverseReactions_original": "• History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) \n    • During or within 14 days following the administration of monoamine oxidase inhibitors \n    • Hyperthyroidism \n    • Glaucoma \n    • Agitated states \n    • History of drug abuse \n    • Pregnancy (see\n \n  \n                        Precautions\n                     ) \n    • Nursing (see\n \n  \n                        Precautions\n                     ) \n    • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines"
}